Frank-Thorsten Hafner

Director Process Support DMPK-PKBA bei Bayer Pharmaceuticals

Wuppertal, North Rhine-Westphalia, Germany

About

Preclinical PK-Expert in research and development DMPK with more than 20 years of special expertise in the field of analytical chemistry e.g. HPLC-MS/MS. More than 15 years of expertise in method development in compliance with pertinent guidelines. DMPK representative in interdisciplinary global project teams representing Nonclinical PK, Metabolism and Bioanalytics (preclinical + clinical until Phase IV) in various indication areas. DMPK-monitor responsible for the successful submission of the preclinical DMPK package of the oncology drug Stivarga (regorafenib).

Experience

  • Bayer Pharmaceuticals (10 yrs 3 mos)
    • Director Data Handling & Process Support DMPK-PKBA
      Aug 2018 - Present · 7 yrs 11 mos

    • Senior Scientist Bioanalytics Process Support
      Apr 2016 - Aug 2018 · 2 yrs 5 mos

      Mentor for younger colleagues including development of scientific expertise in the field of ADMET with special focus on bioanalytics in a GxP regulated environment. Scientific responsibility for the implementation of a new bioanalytical LIMS in compliance with pertinent guidelines.

  • Senior Scientist at Bayer AG
    May 2008 - Apr 2016 · 8 yrs

    Head of Laboratory Bioanalytics Wuppertal

  • Research Scientist at Bayer HealthCare
    Jul 2007 - Apr 2008 · 10 mos

    Research Scientist Bioanalytics Wuppertal

  • Research Scientist at Bayer
    Oct 2000 - May 2003 · 2 yrs 8 mos

    Research Pharmacokinetics